Log on / register
BioMed Central home | Journals A-Z | Feedback | Support
Issue navigator


 


Contents of Volume 7 Suppl 2
Basic science, rationale, background and future of abatacept
Reviews
Edited by Peter E Lipsky and Ravinder N Maini
Supported by an educational grant from Bristol-Myers Squibb Company

Introduction    
The science of rheumatoid arthritis: a prelude
Josef S Smolen
Arthritis Research & Therapy 2005, 7(Suppl 2):S1-S3 (16 March 2005)
[Full text] [PDF] [PubMed] [Related articles]

Review    
The role of the T cell in autoimmune inflammation
Alla Skapenko, Jan Leipe, Peter E Lipsky, Hendrik Schulze-Koops
Arthritis Research & Therapy 2005, 7(Suppl 2):S4-S14 (16 March 2005)
[Full text] [PDF] [PubMed] [Related articles]

Review    
Modulating co-stimulation: a rational strategy in the treatment of rheumatoid arthritis?
Vivianne Malmström, Christina Trollmo, Lars Klareskog
Arthritis Research & Therapy 2005, 7(Suppl 2):S15-S20 (16 March 2005)
[Full text] [PDF] [PubMed] [Related articles]

Review    
The evolving clinical profile of abatacept (CTLA4Ig): a novel co-stimulatory modulator for the treatment of rheumatoid arthritis
Eric M Ruderman, Richard M Pope
Arthritis Research & Therapy 2005, 7(Suppl 2):S21-S25 (16 March 2005)
[Full text] [PDF] [PubMed] [Related articles]

edit my details
Arthritis Research & Therapy
BioMed Central
Current Controlled
Trials
PubMed
PubMed Central



© 1999-2008 BioMed Central Ltd unless otherwise stated < info@arthritis-research.com >   Terms and conditions